Samsung BioLogics Co (XKRX:207940) Deferred Tax : ₩299,243 Mil (TTM As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Samsung BioLogics Co's change in deferred tax for the three months ended in Sep. 2024 was ₩26,531 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2024 was ₩299,243 Mil.

Samsung BioLogics Co Deferred Tax Historical Data

The historical data trend for Samsung BioLogics Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co Deferred Tax Chart

Samsung BioLogics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Deferred Tax

Get a 7-Day Free Trial

-47,468.79

25,017.36

167,693.13

210,968.36

262,295.63

Samsung BioLogics Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Deferred Tax	Get a 7-Day Free Trial															75,946.34	65,028.48	60,715.26	146,968.00	26,530.88

Samsung BioLogics Co Deferred Tax Calculation

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩299,243 Mil.

Samsung BioLogics Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of Samsung BioLogics Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Samsung BioLogics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » Deferred Tax

Comparable Companies

Traded in Other Exchanges

N/A

Address

125, Cheomdan-daero, Yeonsu-gu, Incheon, KOR

Website

https://www.samsungbiologics.com

Founded in 2011, Samsung Biologics is a South Korean contract development and manufacturing organization with a global client base. Europe and the US contribute 90% of its total revenue. It provides end-to-end development and manufacturing services from cell line developments to final commercial manufacturing. As of 2023, Samsung Biologics had a total production capacity of 604,000 liters, one of the largest in the world. Its CDMO services account for 72.4% of its total revenue. The balance comes from subsidiary Samsung Bioepis, acquired in 2022. Samsung Bioepis is involved in developing and manufacturing biosimilars.

Samsung BioLogics Co Headlines

No Headlines